Feng Xinyi, Deng Zhengyi, McCullough Michelle S, May Betty J, Selznick Erica, Sheng Jennifer Y, Connor Avonne E, Armstrong Deborah K, Visvanathan Kala
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Room E6142, Baltimore, MD, 21205, USA.
The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Breast Cancer Res Treat. 2025 Apr;210(3):737-748. doi: 10.1007/s10549-025-07611-y. Epub 2025 Feb 10.
To examine the effect of selected cardiovascular disease (CVD) risk factors over time on early cancer outcomes in breast cancer (BC) survivors.
A prospective study was conducted among women aged 20-65 years with an incident invasive BC enrolled in the Breast and Ovarian Surveillance Service (BOSS) Cohort between 2005 and 2013. CVD risk based on selected risk factors was assessed at baseline and two follow-ups. Participants were categorized into low, medium, and high-risk groups. The primary outcome was BC recurrence (distant or local) or second primary cancer (SPC). Kaplan-Meier failure curves and multivariable Cox proportional hazard models were performed to compare the hazards across CVD risk score groups.
A total of 212 women with invasive BC contributed to 2211 person-years (median follow-up 11.7 years), 103 had low, 73 medium, and 36 high CVD risk scores at baseline. In multivariable analyses, BC survivors with medium CVD risk score had 2.09 times higher risk (95%CI = 1.09-4.02; p = 0.027) of recurrence/SPC compared to survivors with low CVD risk score. This association was particularly pronounced in postmenopausal women, those with estrogen receptor-positive BC, regional disease, or newly diagnosed BC. After excluding women taking cardiac medications, a higher risk of recurrence/SPC was also observed among those in the high-CVD-risk-score group, although not significant.
Higher CVD risk score based on selected risk factors was significantly associated with BC recurrence or SPC, particularly in certain subgroups. Monitoring and treating a combination of CVD risk factors in BC survivors may help reduce BC progression.
研究特定心血管疾病(CVD)风险因素随时间变化对乳腺癌(BC)幸存者早期癌症结局的影响。
对2005年至2013年间纳入乳腺和卵巢监测服务(BOSS)队列的20 - 65岁新发浸润性BC女性进行了一项前瞻性研究。在基线和两次随访时评估基于特定风险因素的CVD风险。参与者被分为低、中、高风险组。主要结局是BC复发(远处或局部)或第二原发性癌症(SPC)。采用Kaplan-Meier失败曲线和多变量Cox比例风险模型比较不同CVD风险评分组之间的风险。
共有212例浸润性BC女性贡献了2211人年(中位随访11.7年),基线时103人CVD风险评分低,73人中等,36人高。在多变量分析中,与CVD风险评分低的幸存者相比,CVD风险评分中等的BC幸存者复发/SPC风险高2.09倍(95%CI = 1.09 - 4.02;p = 0.027)。这种关联在绝经后女性、雌激素受体阳性BC患者、局部疾病患者或新诊断的BC患者中尤为明显。在排除服用心脏药物的女性后,CVD风险评分高的组中也观察到较高的复发/SPC风险,尽管不显著。
基于特定风险因素的较高CVD风险评分与BC复发或SPC显著相关,特别是在某些亚组中。监测和治疗BC幸存者的多种CVD风险因素可能有助于减少BC进展。